The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design

Laura Bonanni, Annachiara Cagnin, Federica Agosta, Claudio Babiloni, Barbara Borroni, Marco Bozzali, Amalia Cecilia Bruni, Massimo Filippi, Daniela Galimberti, Roberto Monastero, Cristina Muscio, Lucilla Parnetti, Daniela Perani, Laura Serra, Vincenzo Silani, Pietro Tiraboschi, Alessandro Padovani, on behalf of DLB-SINdem study group, Annamaria Confaloni, luana vaianella

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Dementia with Lewy bodies (DLB) causes elevated outlays for the National Health Systems due to high institutionalization rate and patients' reduced quality of life and high mortality. Furthermore, DLB is often misdiagnosed as Alzheimer's disease. These data motivate harmonized multicenter longitudinal cohort studies to improve clinical management and therapy monitoring. The Italian DLB study group of the Italian Neurological Society for dementia (SINdem) developed and emailed a semi-structured questionnaire to 572 national dementia centers (from primary to tertiary) to prepare an Italian large longitudinal cohort. The questionnaire surveyed: (1) prevalence and incidence of DLB; (2) clinical assessment; (3) relevance and availability of diagnostic tools; (4) pharmacological management of cognitive, motor, and behavioural disturbances; (5) causes of hospitalization, with specific focus on delirium and its treatment. Overall, 135 centers (23.6 %) contributed to the survey. Overall, 5624 patients with DLB are currently followed by the 135 centers in a year (2042 of them are new patients). The percentage of DLB patients was lower (27 ± 8 %) than that of Alzheimer's disease and frontotemporal dementia (56 ± 27 %) patients. The majority of the centers (91 %) considered the clinical and neuropsychological assessments as the most relevant procedure for a DLB diagnosis. Nonetheless, most of the centers has availability of magnetic resonance imaging (MRI; 95 %), electroencephalography (EEG; 93 %), and FP-CIT single photon emission-computerized tomography (SPECT; 75 %) scan for clinical applications. It will be, therefore, possible to recruit a large harmonized Italian cohort of DLB patients for future cross-sectional and longitudinal multicenter studies.
Original languageEnglish
Pages (from-to)83-91
Number of pages9
JournalNeurological Sciences
Volume38
Issue number1
Publication statusPublished - 2017

Fingerprint

Lewy Body Disease
Multicenter Studies
Cohort Studies
Single-Photon Emission-Computed Tomography
Longitudinal Studies
Dementia
Electroencephalography
Alzheimer Disease
Frontotemporal Dementia
Institutionalization
Delirium
Diagnostic Errors
Hospitalization
Quality of Life
Magnetic Resonance Imaging
Pharmacology
Mortality
Incidence
Health
Therapeutics

Keywords

  • dementia
  • LBD

Cite this

Bonanni, L., Cagnin, A., Agosta, F., Babiloni, C., Borroni, B., Bozzali, M., ... vaianella, L. (2017). The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design. Neurological Sciences, 38(1), 83-91.

The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design. / Bonanni, Laura; Cagnin, Annachiara; Agosta, Federica; Babiloni, Claudio; Borroni, Barbara; Bozzali, Marco; Bruni, Amalia Cecilia; Filippi, Massimo; Galimberti, Daniela; Monastero, Roberto; Muscio, Cristina; Parnetti, Lucilla; Perani, Daniela; Serra, Laura; Silani, Vincenzo; Tiraboschi, Pietro; Padovani, Alessandro; group, on behalf of DLB-SINdem study; Confaloni, Annamaria; vaianella, luana.

In: Neurological Sciences, Vol. 38, No. 1, 2017, p. 83-91.

Research output: Contribution to journalArticle

Bonanni, L, Cagnin, A, Agosta, F, Babiloni, C, Borroni, B, Bozzali, M, Bruni, AC, Filippi, M, Galimberti, D, Monastero, R, Muscio, C, Parnetti, L, Perani, D, Serra, L, Silani, V, Tiraboschi, P, Padovani, A, group, OBODLB-SINS, Confaloni, A & vaianella, L 2017, 'The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design', Neurological Sciences, vol. 38, no. 1, pp. 83-91.
Bonanni, Laura ; Cagnin, Annachiara ; Agosta, Federica ; Babiloni, Claudio ; Borroni, Barbara ; Bozzali, Marco ; Bruni, Amalia Cecilia ; Filippi, Massimo ; Galimberti, Daniela ; Monastero, Roberto ; Muscio, Cristina ; Parnetti, Lucilla ; Perani, Daniela ; Serra, Laura ; Silani, Vincenzo ; Tiraboschi, Pietro ; Padovani, Alessandro ; group, on behalf of DLB-SINdem study ; Confaloni, Annamaria ; vaianella, luana. / The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design. In: Neurological Sciences. 2017 ; Vol. 38, No. 1. pp. 83-91.
@article{0ec0d1369b3c432088d3d7dba8538e50,
title = "The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design",
abstract = "Dementia with Lewy bodies (DLB) causes elevated outlays for the National Health Systems due to high institutionalization rate and patients' reduced quality of life and high mortality. Furthermore, DLB is often misdiagnosed as Alzheimer's disease. These data motivate harmonized multicenter longitudinal cohort studies to improve clinical management and therapy monitoring. The Italian DLB study group of the Italian Neurological Society for dementia (SINdem) developed and emailed a semi-structured questionnaire to 572 national dementia centers (from primary to tertiary) to prepare an Italian large longitudinal cohort. The questionnaire surveyed: (1) prevalence and incidence of DLB; (2) clinical assessment; (3) relevance and availability of diagnostic tools; (4) pharmacological management of cognitive, motor, and behavioural disturbances; (5) causes of hospitalization, with specific focus on delirium and its treatment. Overall, 135 centers (23.6 {\%}) contributed to the survey. Overall, 5624 patients with DLB are currently followed by the 135 centers in a year (2042 of them are new patients). The percentage of DLB patients was lower (27 ± 8 {\%}) than that of Alzheimer's disease and frontotemporal dementia (56 ± 27 {\%}) patients. The majority of the centers (91 {\%}) considered the clinical and neuropsychological assessments as the most relevant procedure for a DLB diagnosis. Nonetheless, most of the centers has availability of magnetic resonance imaging (MRI; 95 {\%}), electroencephalography (EEG; 93 {\%}), and FP-CIT single photon emission-computerized tomography (SPECT; 75 {\%}) scan for clinical applications. It will be, therefore, possible to recruit a large harmonized Italian cohort of DLB patients for future cross-sectional and longitudinal multicenter studies.",
keywords = "dementia, LBD",
author = "Laura Bonanni and Annachiara Cagnin and Federica Agosta and Claudio Babiloni and Barbara Borroni and Marco Bozzali and Bruni, {Amalia Cecilia} and Massimo Filippi and Daniela Galimberti and Roberto Monastero and Cristina Muscio and Lucilla Parnetti and Daniela Perani and Laura Serra and Vincenzo Silani and Pietro Tiraboschi and Alessandro Padovani and group, {on behalf of DLB-SINdem study} and Annamaria Confaloni and luana vaianella",
year = "2017",
language = "English",
volume = "38",
pages = "83--91",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",
number = "1",

}

TY - JOUR

T1 - The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design

AU - Bonanni, Laura

AU - Cagnin, Annachiara

AU - Agosta, Federica

AU - Babiloni, Claudio

AU - Borroni, Barbara

AU - Bozzali, Marco

AU - Bruni, Amalia Cecilia

AU - Filippi, Massimo

AU - Galimberti, Daniela

AU - Monastero, Roberto

AU - Muscio, Cristina

AU - Parnetti, Lucilla

AU - Perani, Daniela

AU - Serra, Laura

AU - Silani, Vincenzo

AU - Tiraboschi, Pietro

AU - Padovani, Alessandro

AU - group, on behalf of DLB-SINdem study

AU - Confaloni, Annamaria

AU - vaianella, luana

PY - 2017

Y1 - 2017

N2 - Dementia with Lewy bodies (DLB) causes elevated outlays for the National Health Systems due to high institutionalization rate and patients' reduced quality of life and high mortality. Furthermore, DLB is often misdiagnosed as Alzheimer's disease. These data motivate harmonized multicenter longitudinal cohort studies to improve clinical management and therapy monitoring. The Italian DLB study group of the Italian Neurological Society for dementia (SINdem) developed and emailed a semi-structured questionnaire to 572 national dementia centers (from primary to tertiary) to prepare an Italian large longitudinal cohort. The questionnaire surveyed: (1) prevalence and incidence of DLB; (2) clinical assessment; (3) relevance and availability of diagnostic tools; (4) pharmacological management of cognitive, motor, and behavioural disturbances; (5) causes of hospitalization, with specific focus on delirium and its treatment. Overall, 135 centers (23.6 %) contributed to the survey. Overall, 5624 patients with DLB are currently followed by the 135 centers in a year (2042 of them are new patients). The percentage of DLB patients was lower (27 ± 8 %) than that of Alzheimer's disease and frontotemporal dementia (56 ± 27 %) patients. The majority of the centers (91 %) considered the clinical and neuropsychological assessments as the most relevant procedure for a DLB diagnosis. Nonetheless, most of the centers has availability of magnetic resonance imaging (MRI; 95 %), electroencephalography (EEG; 93 %), and FP-CIT single photon emission-computerized tomography (SPECT; 75 %) scan for clinical applications. It will be, therefore, possible to recruit a large harmonized Italian cohort of DLB patients for future cross-sectional and longitudinal multicenter studies.

AB - Dementia with Lewy bodies (DLB) causes elevated outlays for the National Health Systems due to high institutionalization rate and patients' reduced quality of life and high mortality. Furthermore, DLB is often misdiagnosed as Alzheimer's disease. These data motivate harmonized multicenter longitudinal cohort studies to improve clinical management and therapy monitoring. The Italian DLB study group of the Italian Neurological Society for dementia (SINdem) developed and emailed a semi-structured questionnaire to 572 national dementia centers (from primary to tertiary) to prepare an Italian large longitudinal cohort. The questionnaire surveyed: (1) prevalence and incidence of DLB; (2) clinical assessment; (3) relevance and availability of diagnostic tools; (4) pharmacological management of cognitive, motor, and behavioural disturbances; (5) causes of hospitalization, with specific focus on delirium and its treatment. Overall, 135 centers (23.6 %) contributed to the survey. Overall, 5624 patients with DLB are currently followed by the 135 centers in a year (2042 of them are new patients). The percentage of DLB patients was lower (27 ± 8 %) than that of Alzheimer's disease and frontotemporal dementia (56 ± 27 %) patients. The majority of the centers (91 %) considered the clinical and neuropsychological assessments as the most relevant procedure for a DLB diagnosis. Nonetheless, most of the centers has availability of magnetic resonance imaging (MRI; 95 %), electroencephalography (EEG; 93 %), and FP-CIT single photon emission-computerized tomography (SPECT; 75 %) scan for clinical applications. It will be, therefore, possible to recruit a large harmonized Italian cohort of DLB patients for future cross-sectional and longitudinal multicenter studies.

KW - dementia

KW - LBD

M3 - Article

VL - 38

SP - 83

EP - 91

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - 1

ER -